These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 29280199)
21. Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering. Wang Y; Tian Z; Thirumalai D; Zhang X J Drug Target; 2014 May; 22(4):269-78. PubMed ID: 24404896 [TBL] [Abstract][Full Text] [Related]
22. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution. Pollastrini J; Dillon TM; Bondarenko P; Chou RY Anal Biochem; 2011 Jul; 414(1):88-98. PubMed ID: 21385563 [TBL] [Abstract][Full Text] [Related]
23. Immobilization and functional reconstitution of antibody Fab fragment by solid-phase refolding. Kumada Y; Hamasaki K; Nakagawa A; Sasaki E; Shirai T; Okumura M; Inoue M; Kishimoto M J Immunol Methods; 2013 Dec; 400-401():70-7. PubMed ID: 24177435 [TBL] [Abstract][Full Text] [Related]
24. Modeling approach to investigate the effect of neonatal Fc receptor binding affinity and anti-therapeutic antibody on the pharmacokinetic of humanized monoclonal anti-tumor necrosis factor-α IgG antibody in cynomolgus monkey. Ng CM; Loyet KM; Iyer S; Fielder PJ; Deng R Eur J Pharm Sci; 2014 Jan; 51():51-8. PubMed ID: 23999033 [TBL] [Abstract][Full Text] [Related]
25. Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Vaccaro C; Zhou J; Ober RJ; Ward ES Nat Biotechnol; 2005 Oct; 23(10):1283-8. PubMed ID: 16186811 [TBL] [Abstract][Full Text] [Related]
26. Fabrication of an antibody microwell array with self-adhering antibody binding protein. Tanaka G; Funabashi H; Mie M; Kobatake E Anal Biochem; 2006 Mar; 350(2):298-303. PubMed ID: 16455038 [TBL] [Abstract][Full Text] [Related]
27. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction. Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461 [TBL] [Abstract][Full Text] [Related]
28. Presence of an antigenic determinant common to rat IgE-potentiating factor, IgE-suppressive factor, and Fc epsilon receptors on T and B lymphocytes. Huff TF; Yodoi J; Uede T; Ishizaka K J Immunol; 1984 Jan; 132(1):406-12. PubMed ID: 6197453 [TBL] [Abstract][Full Text] [Related]
29. Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates. Yeung YA; Leabman MK; Marvin JS; Qiu J; Adams CW; Lien S; Starovasnik MA; Lowman HB J Immunol; 2009 Jun; 182(12):7663-71. PubMed ID: 19494290 [TBL] [Abstract][Full Text] [Related]
30. Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms. Jaramillo CAC; Belli S; Cascais AC; Dudal S; Edelmann MR; Haak M; Brun ME; Otteneder MB; Ullah M; Funk C; Schuler F; Simon S MAbs; 2017 Jul; 9(5):781-791. PubMed ID: 28440708 [TBL] [Abstract][Full Text] [Related]
31. Discovery and structure-activity relationships of small molecules that block the human immunoglobulin G-human neonatal Fc receptor (hIgG-hFcRn) protein-protein interaction. Wang Z; Fraley C; Mezo AR Bioorg Med Chem Lett; 2013 Mar; 23(5):1253-6. PubMed ID: 23375228 [TBL] [Abstract][Full Text] [Related]
32. Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics. Schoch A; Kettenberger H; Mundigl O; Winter G; Engert J; Heinrich J; Emrich T Proc Natl Acad Sci U S A; 2015 May; 112(19):5997-6002. PubMed ID: 25918417 [TBL] [Abstract][Full Text] [Related]
33. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells. Adachi M; Yodoi J; Noro N; Masuda T; Uchino H J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376 [TBL] [Abstract][Full Text] [Related]
34. Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions. Grevys A; Bern M; Foss S; Bratlie DB; Moen A; Gunnarsen KS; Aase A; Michaelsen TE; Sandlie I; Andersen JT J Immunol; 2015 Jun; 194(11):5497-508. PubMed ID: 25904551 [TBL] [Abstract][Full Text] [Related]
35. A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies. Stracke J; Emrich T; Rueger P; Schlothauer T; Kling L; Knaupp A; Hertenberger H; Wolfert A; Spick C; Lau W; Drabner G; Reiff U; Koll H; Papadimitriou A MAbs; 2014; 6(5):1229-42. PubMed ID: 25517308 [TBL] [Abstract][Full Text] [Related]
36. Expression of soluble and functional human neonatal Fc receptor in Pichia pastoris. Lee CH; Choi DK; Choi HJ; Song MY; Kim YS Protein Expr Purif; 2010 May; 71(1):42-8. PubMed ID: 20006709 [TBL] [Abstract][Full Text] [Related]
37. Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn. Cooper PR; Ciambrone GJ; Kliwinski CM; Maze E; Johnson L; Li Q; Feng Y; Hornby PJ Brain Res; 2013 Oct; 1534():13-21. PubMed ID: 23978455 [TBL] [Abstract][Full Text] [Related]
38. A new method for multilayered, site-directed immobilization of antibody on polystyrene surface. Feng B; Wang C; Xie X; Feng X; Li Y; Cao Z Biochem Biophys Res Commun; 2014 Jul; 450(1):429-32. PubMed ID: 24909694 [TBL] [Abstract][Full Text] [Related]
39. Development and applications of AlphaScreen-based FcRn binding assay to characterize monoclonal antibodies. Wu Q; Lee HY; Wong PY; Jiang G; Gazzano-Santoro H J Immunol Methods; 2015 May; 420():31-7. PubMed ID: 25837414 [TBL] [Abstract][Full Text] [Related]
40. Expression and characterization of rubella virus glycoprotein E1 in yeast cells. Wen H; Wang Z Intervirology; 2005; 48(5):321-8. PubMed ID: 15956800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]